Cargando…
The Anthelmintic Activity of Praziquantel Analogs Correlates with Structure–Activity Relationships at TRPM(PZQ) Orthologs
[Image: see text] The anthelmintic drug praziquantel remains a key clinical therapy for treating various diseases caused by parasitic flatworms. The parasite target of praziquantel has remained undefined despite longstanding usage in the clinic, although a candidate ion channel target, named TRPM(PZ...
Autores principales: | Sprague, Daniel J., Kaethner, Marc, Park, Sang-Kyu, Rohr, Claudia M., Harris, Jade L., Maillard, David, Spangenberg, Thomas, Lundström-Stadelmann, Britta, Marchant, Jonathan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641913/ https://www.ncbi.nlm.nih.gov/pubmed/37970586 http://dx.doi.org/10.1021/acsmedchemlett.3c00350 |
Ejemplares similares
-
Natural variation in the binding pocket of a parasitic flatworm TRPM channel resolves the basis for praziquantel sensitivity
por: Rohr, Claudia M., et al.
Publicado: (2022) -
Comparative palatability of orally disintegrating tablets (ODTs) of Praziquantel (L-PZQ and Rac-PZQ) versus current PZQ tablet in African children: A randomized, single-blind, crossover study
por: Mahende, Muhidin K., et al.
Publicado: (2021) -
Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for Schistosomiasis
por: Bustinduy, Amaya L., et al.
Publicado: (2016) -
Morphological Characteristics of Schistosoma mansoni PZQ-Resistant and -Susceptible Strains Are Different in Presence of Praziquantel
por: Pinto-Almeida, António, et al.
Publicado: (2016) -
The anthelmintic drug praziquantel activates a schistosome transient receptor potential channel
por: Park, Sang-Kyu, et al.
Publicado: (2019)